Hook & thesis
Equifax reported Q3 results on 10/20/2026 that largely validated ongoing secular demand for data and identity services while exposing cyclical sensitivity to mortgage activity. The headline beat - $1.69 billion in revenue and $2.26 adjusted EPS - came with a tempered full-year revenue midpoint driven by weak U.S. mortgage origination. That dynamic is important, but it obscures two investment-grade arguments: (1) durable secular growth across Workforce Solutions, International and USIS, and (2) near-term margin expansion from AI-driven efficiency and large-contract wins, including a disclosed $550 million annual government contract. Those items can materially change profit trajectory and justify stepping into a long that targets a re-rating from current multiples.
I recommend a tactical long in EFX at an entry of $176.60. The trade is sized as a position to hold over the long-term horizon (180 trading days) to capture margin expansion and multiple expansion if mortgage markets stabilize. Stop at $155.00$210.00. The plan balances a clear upside skew with defined downside protection should mortgage weakness persist or execution disappoint.
What Equifax does and why the market should care
Equifax is a global data, analytics and technology company selling consumer and commercial information services, identity solutions, workforce verification and related decisioning tools. The market cares because Equifax packages information assets into high-margin subscription products that scale with small incremental costs and high switching frictions. The firm’s three segments - U.S. Information Solutions (USIS), Workforce Solutions, and International - together create a diversified revenue base where secular drivers (digital identity, fraud, employment verification, and data-driven marketing) persist even if mortgage origination lags.
Recent fundamentals and the trigger points
- Q3 results (reported 10/20/2026): revenue $1.69B, up ~9.6% year-over-year; adjusted EPS $2.26, up ~10.8% YoY. These are beats and show underlying businesses growing despite mortgage headwinds.
- Management disclosed a $550M annual government contract value in workforce verification - a meaningful, recurring revenue stream that improves revenue visibility in coming years.
- Management pointed to accelerated adoption of VantageScore among mortgage lenders and deployment of AI tools to improve operational efficiency - both catalysts for revenue and margin upside when mortgage flow resumes.
- 2026 revenue guidance midpoint was cut to $6.661B reflecting weaker mortgage demand, clarifying the near-term ceiling on top-line growth but not the structural growth profile elsewhere.
Valuation framing
Equifax trades with a market cap around $20.7B and enterprise value near $26.04B. Key multiples: P/E roughly ~30x, price-to-sales ~3.2x, EV/EBITDA ~13.7x, and free cash flow approximately $1.105B annually. Those multiples reflect a mix of durable growth and some cyclical risk.
Put simply, the market is pricing in a high-quality grower with margin optionality but also the potential for prolonged weakness in mortgage-driven revenue. If Equifax can convert AI-led efficiency and the government contract into incremental EBITDA margin, the current EV/EBITDA multiple can be justified or even expanded. Conversely, extended mortgage lethargy would maintain pressure on revenue and average multiples.
| Metric | Value |
|---|---|
| Market cap | $20.7B |
| Enterprise value | $26.04B |
| Free cash flow | $1.105B |
| P/E (trailing) | ~30x |
| EV/EBITDA | ~13.7x |
Catalysts to watch
- AI-driven margin acceleration - management flagged AI deployments improving operating efficiency. If realized, this should show up as expanding operating margins and higher FCF conversion over the next 2-4 quarters.
- Monetization of the $550M government contract - visible sign-ups or a backlog build would materially raise revenue visibility.
- VantageScore adoption by mortgage lenders - a renewed mortgage cycle or faster adoption would unlock upside in USIS and mortgage-related revenue streams.
- Analyst revisions and multiple re-rating - beat-and-raise quarters could compress the risk premium applied to the stock and drive multiple expansion.
- Macroeconomic tailwinds - meaningful decline in mortgage rates would be a big swing factor for incremental revenue and investor sentiment.
Trade plan (actionable)
Entry: $176.60
Target: $210.00
Stop-loss: $155.00
Horizon: long term (180 trading days). Rationale - the thesis depends on operational execution (AI efficiency), contract ramp and the broader mortgage cycle normalizing. Those developments typically play out over multiple quarters, so a 180 trading day horizon gives room for both execution and re-rating.
Positioning note: size the trade so that the stop represents an acceptable capital loss relative to your portfolio tolerance. The stop at $155 protects against sustained multiple compression or worse-than-expected mortgage deterioration.
Risks and counterarguments
- Prolonged mortgage weakness - The company explicitly trimmed guidance due to mortgage demand. If mortgage origination remains depressed for many quarters, the top-line and valuation case suffers materially.
- Execution risk on AI initiatives - Management has indicated efficiency gains from AI, but those may take time to deliver or fall short of expectations; margin expansion could be delayed or muted.
- Regulatory and privacy risk - As a steward of sensitive consumer data, Equifax faces regulatory scrutiny and potential cost from evolving privacy rules which could weigh on margins and drive higher compliance spend.
- Cybersecurity risk - Any material breach or security issue could damage trust, result in fines and materially impair growth in identity and consumer-facing products.
- Valuation vulnerability - Trading at ~30x earnings and 13.7x EV/EBITDA, the stock has limited margin for error; misses or another cut in guidance could compress multiples quickly.
Counterargument: The market is right to discount Equifax until mortgage flows normalize. A scenario where mortgage rates stay elevated and lenders delay adoption of VantageScore would substantively reduce potential upside and keep the name range-bound or lower. In that case, the safer path would be to wait for clearer signs of mortgage recovery or consistent margin expansion before adding exposure.
Conclusion - what would change my mind
My base case is constructive: Equifax’s diversified revenue base, the $550M government contract, and AI-driven margin opportunity create a pathway to meaningful earnings and cash flow upside that supports a re-rating from current multiples. That underpins the tactical long at $176.60 with a $210 target over 180 trading days.
On the other hand, I would change my view to bearish if any of the following occur: a) management materially cuts FY2026 guidance again, b) mortgage rates remain structurally higher and VantageScore adoption stalls, c) signs that AI efficiency initiatives are not delivering cost savings in the next two quarters, or d) a major cybersecurity incident or regulatory penalty surfaces. Any of those would argue for tightening stops, reducing exposure, or exiting the position.
Action items: enter at $176.60, place a stop at $155.00, and reassess at every quarterly release or if any of the catalysts hit material milestones. If Equifax reports consecutive quarters of margin expansion and visible contract ramp, consider raising the target or converting this into a core holding.